Americann Inc
OTC:ACAN

Watchlist Manager
Americann Inc Logo
Americann Inc
OTC:ACAN
Watchlist
Price: 0.0001 USD
Market Cap: 2.4k USD

Relative Value

ACAN doesn't have a meaningful market cap.

The Relative Value of one ACAN stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.0001 USD, Americann Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACAN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
71
Median 3Y
0.8
Median 5Y
1.7
Industry
2.6
vs History
vs Industry
39
Median 3Y
-0.2
Median 5Y
-3.4
Industry
21.4
vs History
vs Industry
26
Median 3Y
-0
Median 5Y
-0
Industry
16.4
vs History
vs Industry
7
Median 3Y
-0.6
Median 5Y
-13.5
Industry
22.8
vs History
87
vs Industry
80
Median 3Y
0.3
Median 5Y
0.8
Industry
2.2
vs History
36
vs Industry
19
Median 3Y
3.6
Median 5Y
5.7
Industry
2.9
vs History
20
vs Industry
29
Median 3Y
3.6
Median 5Y
3.7
Industry
5.5
vs History
vs Industry
32
Median 3Y
5.6
Median 5Y
6.1
Industry
13
vs History
vs Industry
3
Median 3Y
-4.3
Median 5Y
-4.3
Industry
16.5
vs History
vs Industry
8
Median 3Y
-3.5
Median 5Y
-3.5
Industry
15.6
vs History
vs Industry
22
Median 3Y
-3.5
Median 5Y
-3.5
Industry
18.7
vs History
66
vs Industry
72
Median 3Y
0.5
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

ACAN Competitors Multiples
Americann Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Americann Inc
OTC:ACAN
2.4k USD 0 -0 -7 -4.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.5B USD 5.4 19.8 16.2 21.1
CH
Roche Holding AG
SIX:ROG
268.8B CHF 4.4 28.5 12.1 14.2
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP 5.1 31.5 108.7 159.1
US
Merck & Co Inc
NYSE:MRK
277.5B USD 4.3 14.6 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.4B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.8B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Americann Inc
OTC:ACAN
Average P/E: 25.1
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.6
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Americann Inc
OTC:ACAN
Average EV/EBITDA: 440.1
Negative Multiple: -7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Americann Inc
OTC:ACAN
Average EV/EBIT: 1 883.7
Negative Multiple: -4.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5